Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2018-08-13 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: METZ (57000), Moselle
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CHARTON : revenue, balance sheet and financial ratios
PHARMACIE CHARTON is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in METZ (57000),
this company of category PME
shows in 2022 a revenue of 1.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CHARTON (SIREN 841717002)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
1 513 820 €
N/C
N/C
N/C
Net income
117 248 €
114 994 €
161 453 €
109 561 €
133 590 €
70 913 €
EBITDA
N/C
N/C
210 650 €
N/C
N/C
N/C
Net margin
N/C
N/C
10.7%
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE CHARTON generates positive net income of 117 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 71 k€ -> 117 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
117 248 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 85%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
84.593%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.337%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
2116.701
515.99
294.21
166.213
117.848
84.593
Financial autonomy
4.046
14.413
21.964
31.792
39.634
48.337
Repayment capacity
None
None
None
4.643
None
None
Cash flow / Revenue
None%
None%
None%
10.644%
None%
None%
Sector positioning
Debt ratio
84.592024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average-14 pts over 3 years
In 2024, the debt ratio of PHARMACIE CHARTON (84.59) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.34%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average+19 pts over 3 years
In 2024, the financial autonomy of PHARMACIE CHARTON (48.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.64 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE CHARTON (4.64) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 214.86. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
214.859
Liquidity indicators evolution PHARMACIE CHARTON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
109.974
147.039
153.822
169.087
181.466
214.859
Interest coverage
None
None
None
1.999
None
None
Sector positioning
Liquidity ratio
214.862024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good+24 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE CHARTON (214.86) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.0x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE CHARTON (2.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CHARTON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
109 071 €
0 €
0 €
Inventory turnover (days)
0
0
0
30
0
0
Customer payment term (days)
0
0
0
6
0
0
Supplier payment term (days)
0
0
0
49
0
0
Positioning of PHARMACIE CHARTON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CHARTON is estimated at
1 636 868 €
(range 1 139 889€ - 2 448 849€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1139k€1636k€2448k€
1 636 868 €Range: 1 139 889€ - 2 448 849€
NAF 5 année 2024
Valuation method used
Net Income Multiple
117 248 €
×
14.0x
=1 636 869 €
Range: 1 139 890€ - 2 448 849€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CHARTON with other companies in the same sector:
Frequently asked questions about PHARMACIE CHARTON
What is the revenue of PHARMACIE CHARTON ?
The revenue of PHARMACIE CHARTON in 2022 is 1.5 M€.
Is PHARMACIE CHARTON profitable?
Yes, PHARMACIE CHARTON generated a net profit of 117 k€ in 2024.
Where is the headquarters of PHARMACIE CHARTON ?
The headquarters of PHARMACIE CHARTON is located in METZ (57000), in the department Moselle.
Where to find the tax return of PHARMACIE CHARTON ?
The tax return of PHARMACIE CHARTON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CHARTON operate?
PHARMACIE CHARTON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart